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Abstract
Pharmacokinetics, the process that involves drug absorption, distribution,
metabolism and excretion (ADME) of antimicrobials, determines pharmacody-
namic response, that is, what drugs do to the body. Therefore, of all the pharmaco-
kinetic parameters, elimination half-life (T1/2β), volume of distribution (Vd),
maximum plasma concentration (Cmax) and maximum time reached (Tmax) are
the most important parameters. Hence, the parameters are unique in determining
pharmacokinetic and pharmacodynamic response of antimicrobials. However, it is
elimination half-life and minimum inhibitory concentration (MIC) that determine
the dosing interval of antimicrobials. The dose range of 2.5 mg/kg for gentamicin
passing through 4 mg/kg (ciprofloxacin), 4.2 mg/kg (ampicillin L/A), 5 mg/kg
(kanamycin, enrofloxacin, gatifloxacin and norfloxacin), 7 mg/kg (mequindox),
10 mg/kg (amikacin, enrofloxacin, lincomycin, pefloxacin, cefpirome, erythromy-
cin and isoniazid), 20 mg/kg (oxytetracycline) and 30 mg/kg (metronidazole) have
elimination half-life of 1.2–67.2 h, Cmax of 0.12–54.4 μg/ml, Tmax of 0.2–24 h,
bioavailability of 16–99.8% and plasma protein binding of 0–>80% when adminis-
tered intramuscularly, intravenously and orally. Human equivalent dose formula
could be used to extrapolate human-goat therapeutic doses of antimicrobials. How-
ever, some antimicrobials such as sulfadimidine, tulathromycin, oxytetracycline
and azithromycin may have high residues in the milk, kidneys, liver, intestines,
brain and skeletal muscles and may portend high risk of antimicrobial resistance,
hypersensitivity reaction, epidermal necrolysis, Stevens-Johnson syndrome and
other adverse drug reactions.
Keywords: pharmacokinetics, pharmacodynamics, goat, tissue residue,
human equivalent dose, resistance, receptor, agonism, antagonism
1. Introduction
Antimicrobials are either synthetic or natural products (antibiotics) that are
used in killing (bactericidal) or controlling the growth (bacteriostatic) of patho-
genic microbes. Sometimes, antimicrobial and antibiotic are interchangeably used.
Goats belong to species (caprine) and serve as the source of meat and milk [1], and
the money realized from sales meet financial obligations of small- and large-scale
goat farmers [2]. There are up to 800 million goats in the world [3]. The economic
species of goats spread across the globe are not limited to Teddy, Kilis, Ardi, West
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African Dwarf, Black Bengal, Indian native, Murciano-Granadina, Angora, Red
Sokoto, Boer and Nubian goats [4–13]. However, the diseases of goats include
colibacillosis, salmonellosis, staphylococcosis and streptococcosis, among others
[14]. Age, sex, dosage formulation, route of administration and dose of antimicro-
bials affect pharmacokinetics and pharmacodynamics of antimicrobials in goats
[13]. For example, female West African dwarf goats are more sensitive to
sulfadimidine than male West African dwarf goats [15]. There are also intraspecies
differences in pharmacokinetic and pharmacodynamic parameters of domestic goat
(Capra aegagrus hircus) such as West African dwarf, Pakistan, Shiba, Netherland
dwarf, Nubian, Red cross-breed, Angora, Boer, LaMancha, Oberhasli, Toggenburg
as well as wild goats, Capra aegagrus aegagrus (bezoar ibex), Capra aegagrus blythi
(Sindh ibex), Oreamnos americanus (mountain goat), Capra aegagrus chialtanensis
(Chiltan ibex), Capra aegagrus cretica (kri-kri), Capra aegagrus turcmenica (Turk-
men wild goat) and Capra aegagrus pictus [15–20]. However, Capra aegagrus hircus is
the most popular domesticated from their wild progenitor, bezoar (Capra aegagrus)
[21, 22]. Also, antimicrobials such as sulfonamides, trimethoprim-
sulfamethoxazole, aminopenicillins, cephalosporins and quinolones could cause
Stevens-Johnson syndrome in humans that eat goat meat which has the drugs
residues [23] and tissue residues above threshold (2 ppm) could be found in the
skeletal muscle, liver, kidney, milk, brain, intestine, heart and lung of goats which
could portend threat to public health [13]. Although goats are domesticated
10,500 years ago, the genomic regions differentiating domestic goats from wild
goats are associated to genes of the nervous system, immunity and productivity
traits; 20 are common to Capra and Ovis [24] indicating the possible relevance of
pharmacogenomics which is the study of how genes affect animal response to
drugs. Because of unprecedented emergence of resistant bacteria, there is a fervent
need to develop new veterinary drugs [25] using both in vitro and in vivo data that
have been generated from basic, translational and clinical research. Solubility and
permeability affect pharmacokinetics of oral formulations of antimicrobials in
goats. The formulations are tablet, capsule, solution, suspension, etc.
2. Methodology
Intensive literature search was carried out with a view to identifying various
chemical classes, dosage form, routes of administration, therapeutic doses, unique
pharmacokinetic parameters such as elimination half-life, volume of distribution,
bioavailability, concentration maximum, peak time, plasma concentration, mini-
mum inhibitory concentration and spectrum of activities of various antimicrobials
in various breeds of domestic and wild goats. Oral dose formulations of antimicro-
bials have been classified biopharmaceutically, and pharmacokinetic equations used
for calculation of common pharmacokinetic parameters have been highlighted.
Information on pharmacodynamic parameters, intraspecies and interspecies scal-
ing, tissue residues, antimicrobial resistance, rehydration therapy and antimicrobial
intoxication has been elucidated.
3. Results
Kinetic parameters of some antimicrobial drugs used in treatment of microbial
infections in goats, goat-human extrapolated doses of some antimicrobials and half-
life and tissue residues and withdrawal periods of some antimicrobials are presented
in Tables 1–3, respectively.
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Chemical class Name Route Dose
(mg/kg)
T1/2β (h) Bioavailability
(%)
Cmax
(μg/ml)
Tmax (h) Breed Spectrum of activity References
Fluoroquinolone Levofloxacin Subcut 1.25 4.67 — 0.33 — — Gram-negative [26]
Aminoglycoside Kanamycin i.v. 5 2.8  0.02 — 33.6  5.5 — Teddy Gram-negative bacilli [7, 8]
Amikacin i.v. 10 1.94  0.10 — — — Indian native Gram-negative bacilli
Fluoroquinolone Levofloxacin i.v. 10 4.04  024 — 15.51  1.41 — Bengal S. aureus [6, 9,
27, 28]
Ofloxacin i.v. 5 6.20  0.23 32.5 0.81  0.00 — Angora S. aureus
Enrofloxacin i.v. 5 3.93  0.46 — 15.53  1.31 — Egyptian native Wide spectrum of activities
Aminoglycoside Gentamicin i.v., i.m. 5 8.1  1.6 94 — - Markhor Gram-negative spp. [29]
Fluoroquinolone Ciprofloxacin i.v. 4 1.63  0.17 — 4.47  0.33 — Bengal Salmonella spp. [30–32]
Norfloxacin i.m. 5 5.24  1.98 66 2.06  0.42 0.77  0.18 Pakistan native Gram-negative spp.
Gatifloxacin i.v. 5 2.47  0.08 — — — Anaerobes
Glycopeptide Lincomycin i.v. 10 9.99  2.83 — 46.0  7.06 — — Bacteria [33, 34]
i.m. 10 6.19  0.25 — 5.63  2.5 0.2  0.16 Bacteria
Macrolide Tulathromycin Subcut 25 67.2 — 0.12  0.02 24 — Bacteria [35]
Fluoroquinolone Pefloxacin i.v. 10 1.2  021 — — — — E. coli [36]
Oral 20 2.91  0.50 42 2.22  0.48 2.3  0.7 E. coli
Cephalosporin Cefpirome i.v., i.m. 10 2.09  0.08 75 10.97  0.34 — Surti Gram-positive [37]
Macrolide Azithromycin i.v., i.m. 20 45.2 92.2 — — — Bacteria [38, 39]
Erythromycin i.v., i.m. 10 1.41  1.20 98.83 2.99  1.53 — Bacteria
Penicillin Ampicillin
(L/A)
i.v. 4.2 1.71 — 0.26 0.04 Ardi Gram-positive/Gram-negative
microbes
[10]
Danoxaline Mequindox i.v., i.m. 7 1.8 99.8 11.01  2.94 0.67  0.13 — Broad spectrum [40]
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Chemical class Name Route Dose
(mg/kg)
T1/2β (h) Bioavailability
(%)
Cmax
(μg/ml)
Tmax (h) Breed Spectrum of activity References
Tetracycline Oxytetracycline i.v., i.m. 20 27.96  11.66 83.2 13.57  5.83 0.46  0.09 Kilis Broad spectrum [11]
10 West African
dwarf
Isoniazid Oral 10 2.05  0.72 — 3.71  0.40 3.14  0.19 Teddy Antituberculosis [12]
Nitroimidazole Metronidazole i.m. 30 5.87 — 54.4 2.0 Nubian Antiprotozoan; antibacterial [4]
Cephalosporin Ceftriaxone i.m., i.v. 20 1.5–2.03 — 21.51 — — Gram-positive [41]
Fluoroquinolone Marbofloxacin i.m. 2 7.2 — 1.9 — — Gram-negative [42]
Key:—, non-available data.
Table 1.
Kinetic parameters of some antimicrobial drugs used in treatment of microbial infections in goats.
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Antimicrobial Route Dose of drug
(mg/kg)
Weight of
goat (kg)
BSA of goat
(m2)
Goat Km
(m/kg)
Weight of
human (kg)
Height of
human (m)
BSA of
human (m2)
Human Km
(m/kg)
Translated human
dose (mg/kg)
Tulathromycin Subcut 2.5 20 0.76 0.04 78 1.9 1.96 0.025 4
Erythromycin i.m., i.
v.
10, 15 30 1.00 0.03 78 1.9 1.96 0.025 18
Tylosin i.m. 15 22 0.81 0.04 72 1.85 1.85 0.026 23
Pefloxacin i.v. 10 25 0.88 0.04 51.3 1.58 1.42 0.028 14.3
Ciprofloxacin i.v. 10 30 1.00 0.03 48 1.48 1.32 0.028 10.7
Cefpirome i.m., i.
v.
10 32 1.04 0.03 46.5 1.59 1.36 0.029 10.3
Lincomycin i.m. 10 50 1.40 0.03 44.8 1.55 1.31 0.029 10.3
Enrofloxacin i.m. 5 20 0.76 0.04 44 1.63 1.34 0.030 6.7
Norfloxacin i.m. 5 30 1.00 0.03 35.5 1.46 1.13 0.031 4.8
Gatifloxacin i.v. 10 20 0.76 0.04 31.4 1.46 1.05 0.033 12.1
Azithromycin i.v. 20 30 1.00 0.03 43 1.58 1.30 0.030 20
Mequindox i.m., i.
v.
7 30 1.00 0.03 48 1.53 1.35 0.028 7.5
Metronidazole i.m. 30 33 1.07 0.03 49.3 1.60 1.40 0.028 32
Kanamycin i.v. 5 30 1.00 0.03 20 1.58 0.87 0.043 3.5
Gentamicin i.v. 2 20 0.76 0.04 60 1.60 1.56 0.026 3.0
Streptomycin i.v. 10 30 1.00 0.03 51.3 1.58 1.42 0.028 10.7
Difloxacin i.m., i.
v.
5 50.2 1.41 0.03 55 1.70 1.54 0.028 5.4
Levofloxacin i.v. 10 20 0.76 0.04 65 1.70 1.68 0.026 15.4
Ofloxacin i.v. 5 20 0.76 0.04 70 1.50 1.63 0.023 8.7
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Antimicrobial Route Dose of drug
(mg/kg)
Weight of
goat (kg)
BSA of goat
(m2)
Goat Km
(m/kg)
Weight of
human (kg)
Height of
human (m)
BSA of
human (m2)
Human Km
(m/kg)
Translated human
dose (mg/kg)
Ampicillin i.v. 4.2 55 1.50 0.03 45 1.40 1.25 0.028 4.5
Isoniazid Oral 10 40 1.21 0.03 30 1.30 0.97 0.032 9.4
Oxytetracycline i.m., i.
v.
20 40 1.21 0.03 64 1.60 1.61 0.025 24
Amikacin i.m. 10 25 0.88 0.03 56 1.30 1.35 0.024 12.5
Sulfadimidine i.m. 33.3 10.4 0.49 0.05 60 1.20 0.75 0.0125 66.6
Table 2.
Goat-human extrapolated doses of some antimicrobials.
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Antimicrobial Route Dose
(mg/kg)
T1/2β (h) Quantity of residues
(ppm)
Withdrawal
period
Affected organ Consequence(s) References
Tulathromycin Subcut 2.5 61.4  141 days 2.09  1.77 34 days Kidney Nephrosis [5]
Erythromycin i.v., i.m. 10, 15 — 2.06  0.36 — Milk Resistance [39]
Sulfadimidine i.m. 100 26.3–41.9 days 1.24–5.68 >30 days Kidney, liver, brain,
skeletal muscle, intestine,
heart
Steven-Johnson syndrome,
nephrosis
[13]
Tylosin i.m., i.v. 15 6.8 h 1.70  o.03 2 days Milk Possible resistance in kid [43]
Gatifloxacin i.v. 5 12 h 2.00 2 days Milk Resistance in kid [32]
Delafloxacin Subcut, i.m.,
i.v.
5 4.5–6.4 h 1.2–2.1 >1.5 days Milk Resistance in kid [44]
Levofloxacin i.v. 10 4.6–7.3 h 14.7–17.0 12.3–42.3 h Milk Resistance in kid [9]
Ceftazidime i.m., i.v. 10 4.71.1 h 2.4–18.3 4 days Milk Resistance in kid [45]
Table 3.
Half-life, tissue residues and withdrawal period of some antimicrobials.
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3.1 Biopharmaceutical classification of oral antimicrobials
This is a system of classifying antimicrobials based on aqueous solubility and
intestinal permeability. The four major factors being considered in this classification
system are dosage form, dissolution rate, solubility and permeability. Hence, anti-
microbials are tested in vitro and classified into four classes:
Class 1: High solubility  high permeability
Class 2: Low solubility  high permeability
Class 3: High solubility  low permeability
Class 4: Low solubility  low permeability
All the classes of dissolution can occur in a pH range of 1–2, 4–5 and 6–8 [46].
Nevertheless, administration of highly toxic antimicrobials such as aminoglycosides
(e.g. gentamicin) should be monitored since it damages the kidney.
Such drugs are said to have narrow therapeutic range NTRð Þ
¼
Minimum toxic concentration MTCð Þ
Median effective concentration MECð Þ
3.2 Pharmacokinetic equations of antimicrobials
Bioavailability, absorption half-life (T1/2α), mean absorption time (MAT), mean
residence time (MRT), apparent volume of distribution (Vd), volume of distribu-
tion, steady state (Vdss), area under curve (AUC), area under the first moment
curve (AUMC), peak time (Tmax), elimination half-life (T1/2β) and systemic
clearance (Cl) are the pharmacokinetic parameters commonly determined in all
species of animals and humans [7, 9, 47–49]. The most important of all these
parameters are elimination half-life, volume of distribution and plasma concentra-
tion of the antimicrobials.
The pharmacokinetic process of antimicrobials in goats obeys first-order kinetic
(Figures 1 and 2) which could be mono-exponential or bi-exponential. The expo-
nential equation commonly used for determination of pharmacokinetic parameters
is CP = Ae
αt + Be
βt. Other equations are:
T1=2α ¼
0:693MAT
ka
(1)
MAT ¼ 1=ka (2)
MRT ¼
AUMC
AUC
(3)
Vd ¼
Clb
β
(4)
AUC ¼
Dose
Cl
(5)
AUMC ¼ MRT AUC (6)
T1=2β ¼
0:693
β
(7)
Clb ¼
Dose
AUC
(8)
However, peak time (Tmax) and Cmax can be estimated from the pharmacoki-
netic graph [47].
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Figure 2.
Mean plasma concentration-time curves of sulfadimidine (100 mg/kg) when co-administered with piroxicam
(5 mg/kg) to male and female WAD goats following intramuscular administration.
Figure 1.
Mean plasma concentration-time curves of sulfadimidine (100 mg/kg) in male and female WAD goats
following intramuscular administration.
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Dosage rate DRð Þ ¼
bioavailability Fð Þ  dose Dð Þ
dosage interval DIð Þ
(9)
DR ¼
plasma concentration CPð Þ
body clearance Clbð Þ
(10)
Infusion rate Roð Þ ¼ plasma concentration, steady state Cpssð Þ  Clb (11)
Accumulation index ¼
1
fraction lost per dosing interval
(12)
¼
1
1 fraction left in the body
(13)
Loading dose LDð Þ ¼
target Cp Vss
F
(14)
LD ¼ maintenance dose MDð Þ  accumulation index Alð Þ (15)
MD ¼
DR DI
F
(16)
Rate of elimination REð Þ ¼ CL concentration (17)
Bioavailability F%ð Þ ¼
AUC Oral, Sc, Im 100
AUCiv
(18)
4. Discussion
4.1 Comparative pharmacokinetics of antimicrobials in domestic goats
Species variations in response to antimicrobials are very important. Various
antimicrobials from different chemical classes, their routes of administration, doses,
elimination half-life, bioavailability, maximal concentration, peak time, breed and
spectra of activity are presented in Table 1. The therapeutic doses of
fluoroquinolones in goats are 1.2 mg/kg subcut for levofloxacin, 5 mg/kg i.v.
(orfloxacin, enrofloxacin, norfloxacin and gatifloxacin) and 20 mg/kg oral
(pefloxacin). The elimination half-life (2.8  0.02 h) of kanamycin (5 mg/kg) and
half-life (1.94  0.1 h) of amikacin (10 mg/kg) in Teddy and Indian native goat,
respectively, show that the disposition kinetics of aminoglycosides in goats is
dependent on the dose of drugs. Also, disposition kinetics of antimicrobials in goats
could be species dependent. For example, Cmax (236.3  0.00 μg/ml) of
sulfadimidine in West African dwarf (Figure 1) is higher than that of Pakistan
female goat (6.0  3.0 μg/ml) and Shiba goat (2.14  1.05 μg/ml), respectively [16].
Tmax of West African dwarf (1.1  0.3 h) is lower than that of Shiba (2.0  1.2 h)
and Netherland dwarf (2.0  0.5 h), respectively [18, 19]. But Vd (3.9  0.8 L/kg)
in West African dwarf is higher than that of Nubian (0.32  0.0 L/kg), Shiba
(0.4  0.2 L/kg) and cross-breed (0.3–0.5 L/kg), respectively [17, 19, 20],
suggesting the difference in breed response to antimicrobials. However, half-life of
kanamycin (5 mg/kg) was higher in buffaloes (4.35  0.24 h), cow (6.0  0.50 h)
and sheep (3.4  0.1 h) than that of goat (2.8  0.2 h), respectively, indicating that
goat is the species most sensitive to kanamycin among these species of herbivores.
Also, difloxacin is effective at 5 mg/kg [8]. But normal milk reduces the activity of
enrofloxacin against E. coli [50]. However, T1/2β (1.94  0.1 h) of kanamycin for
normal goat is lower than the T1/2β (3.17  0.13 h) for febrile goat. Maintenance of
therapeutic concentration (2 mg/ml) requires a priming dose of 14.73 mg/kg and
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maintenance dose of 13.95 mg/kg at an 8-h interval, respectively [8]. Plasma con-
centration of levofloxacin is higher in healthy goats (15.51  1.41 μg/ml) than
mastitis goats (12.48  1.36 kg/ml). This plasma concentration does not affect
levofloxacin elimination [9].
Since various brands of enrofloxacin have different pharmacokinetic parameters
such as half-life (3.93 0.46; 4.04 0.53; 4.56 1.24 h) and plasma concentrations
(15.53  1.31; 6.75  0.56; 10.40  2.65 μg/ml) [28], dosage formulations may have
sufficient effects on pharmacokinetics and pharmacodynamics of aminoglycosides.
Serum concentration of gentamicin (5 mg/kg) was maintained at 1.5–12 μg/ml for a
period of 6 h. But gentamicin (2.5–3.0 mg/kg i.m.) every 8 h is therapeutically
useful with less risk of nephrotoxicity [29], as daily intravenous administration of
4 mg/kg is effective for 36 h in the treatment of systemic and urinary tract infec-
tions caused by Gram-negative pathogens in goats [30]. Therefore, optimal dosage
regimen, bioequivalence and kinetic parameters of antimicrobials are of clinical
importance [31]. Elimination half-life, Cmax and Tmax of intramuscular
enrofloxacin (2.5 mg/kg) are 5.39  0.96 h, 1.14  0.09 μg/ml and 0.83  0.13 h,
respectively [51]. Gatifloxacin (5 mg/kg) provided minimum inhibitory concentra-
tion (MIC) of 0.1–2 μg/ml for susceptible microorganisms between 6 and 12 h in
healthy and febrile goats, respectively [32]. Elimination half-life (3.98  0.18 h),
Cmax (9.24  1.2 μg/ml), MRT (4.13  0.16 h), Vdss (1.22  0.06 L/kg) and Clb
(0.24  0.01 l/h/kg) of enrofloxacin (5 mg/kg) have been reported [6]. The Vd
(3.35  0.45 L/kg), Clb (0.28  0.03 l/h/kg) and T1/2β (9.99  2.83 h) suggest long
persistence of lincomycin in goat as it can be repeated every 24 hwithMIC (0.6 μg/ml)
for treatment of febrile bacterial infections in goats [33]. But intramuscular lincomycin
can be administered every 12 h [34].
Vancomycin was initially active against methicillin-resistant Staphylococcus, but
presently vancomycin-resistant Staphylococcus has emerged, and vancomycin-
resistant Enterococcus has also emerged due to its usage as feed additive. Hence,
prophylactic use of antibiotics should be highly reduced [52]. Concentration of
pefloxacin (0.25 μg/ml) was maintained in plasma for 6–10 h after oral or intrave-
nous administration. Therefore, intravenous pefloxacin (20 mg/kg) every 6 h or
thrice orally is effective against sensitive pathogenic microbes in goats [36]. But
intravenous dose (10 mg/kg) of ciprofloxacin with T1/2β (2.72  1.04 h), MRT
(3.33  1.42 h), Vdss (3.37  0.8 l/kg) and Clb (19.59  9.05 ml/min/kg), respec-
tively, should be administered every 12 h [53]. Cefpirome (10 mg/kg) every 12 h is
useful when administered intravenously in goats. It is 19.9% plasma protein bound [37]
and so may compete weakly with other plasma-binding drugs such as
sulfadimidine, warfarin, non-steroidal anti-inflammatory drugs and barbiturates.
The long half-life of azithromycin after intravenous (45.2 h) and intramuscular
(32.5 h) administration and MRT of 40.1 h and 60.3 h and bioavailability of 92.2%
[38] show that the drug could be administered every 2 and 3 days, respectively. But
half-life (67.2 h) of tulathromycin (25 mg/kg) indicates that the withdrawal period
of tulathromycin may be long and there may not be a need for repeated doses of the
drug. But elimination of erythromycin is higher in lactating goats (3.18  1.32 h)
than non-lactating goats (1.41 1.20 h) [39] signifying that erythromycin is quickly
removed from the body of non-lactating goats. MIC of erythromycin against Staph-
ylococcus aureus was 0.50 and 0.75 μg/ml [54], respectively. Tylosin (10–15 mg/kg)
was administered to goats both intramuscularly and intravenously. The intramus-
cular bioavailability was 72.6%, and serum protein binding was 37.6%, Cmax
(2.38 μg/ml), Vd (1.7 L/kg), T1/2β (3.04 h), Tmax (4.19 h) and Clb (6.8 ml/kg/min),
respectively. Hence, tylosin should be injected every 14 h [43]. Gentamicin (4mg/kg),
amikacin (10 mg/kg), tobramycin (5 mg/kg), kanamycin (10 mg/kg) and apramycin
(20 mg/kg) may have synergistic or additive antibacterial activity [55]. Intramuscular
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metronidazole can be administered to goats at 10 mg/kg body weight every 12 h [4].
Oxytetracycline (10 mg/kg), ampicillin (20mg/kg) and combination of trimethoprim
(20 mg/kg), sulfamethazine (50 mg/kg) and sulphamethyl phenazine (50 mg/kg) are
effective in treatment of ehrlichiosis [56]. But extensive and very wide use of antimi-
crobial agents in goats may portend very high risk of resistance [57]. Therefore, each
antimicrobial must be studied on species basis for effective and safe use for animal
well-being and public safety in terms of animal product consumption and human/
animal drug resistance [3].
4.2 Pharmacokinetics of antimicrobials in wild goats
Although the information on pharmacokinetics of wild goats is rare, allometric
scaling can be applied for extrapolation of some parameters including Vd and Cl
except T1/2β [58]. Ceftazidime (10 mg/kg) administered to Creole goat showed
high serum concentration, good penetration and high bioavailability of the drug
[45]. But cephalexin (10 mg/kg) administered (subcut, i.m. and i.v.) to Lama glama
showed high bioavailability of 72% (i.m.) and 89% (i.v.), respectively. The MIC90
values of cephalexin against coagulase-positive staphylococci and E. coli were
1.0 μg/ml and 8.0 μg/ml, respectively [59]. But MIC90 value (0.01–0.1 μg/ml) of
ceftazidime against E. coli, Salmonella species, Pasteurella haemolytica and P.
multocida [45] shows that ceftazidime is more active and efficacious than cepha-
lexin, which can be administered 8 mg/kg i.m. or subcut every 12 or 24 h, respec-
tively [59]. Other modes of administration such as ballistic implants and
impregnated beads can be employed for some antimicrobials to avoid frequent
administration as seen in cefovecin with very long half-life in dogs and cats,
allowing a dosing interval of 14 days [60, 61]. This strategy may reduce the chance
of resistance by microorganisms against antimicrobials. For example, an amoxicillin
formulation with half-life of 130 h can be administered every 6 days, and ceftiofur
with half-life of 37 h can be administered every 2 days in goats [62]. Orbifloxacin
administered to Mehsana goat (2.5 mg/kg i.v.) with T1/2β (8.63  0.13 h), Vdss
(2.99  0.04 l/kg), MRT (21.07  0.8 h) and bioavailability (155.5%) showed
antimicrobial activity against E. faecalis, S. epidermidis, S. intermedius, S. aureus,
S. pyogenes, E. coli, S. typhimurium, S. typhi, S. enterica, Shigella flexneri, K. pneumo-
nia, E. aerogenes, P. aeruginosa, P. mirabilis, Pasteurella species, Mycoplasma species
and Mannheimia haemolytica [63].
4.3 Pharmacodynamics of antimicrobials
Pharmacokinetics determine maximal therapeutic effect that depends on plasma
drug concentration, drug receptors, health status and co-administration of antimi-
crobial with another drug that shares same or different binding receptors. Slowly
eliminated and accumulated antimicrobials are least compared by poor dosing
interval [64]. The maximal effect of antimicrobials is dependent on molecule-
receptor interaction and drug-affinity response. Therefore,
Drugs Dð Þ þ receptor Rð Þ⇄
k1DR
k2
(19)
Affinity constant Kaffð Þ ¼
k1
k2
(20)
Kaff ¼
1
ED50
(21)
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However, antimicrobial treatments can be monitored as follows:
Dose newð Þ ¼
Cpss measuredð Þ
Cpss desiredð Þ
Dose previousð Þ (22)
But Cpss is achieved when antimicrobial is administered repeatedly at different
time intervals.
Therapeutic index TIð Þ is defined as a ratio of
Lethal dose fifty LD50ð Þ
Effective dosefifty ED50ð Þ
(23)
Effective dose EDð Þ ¼
CL effective concentration ECð Þ
Bioavailability Fð Þ
(24)
However, when the body weight of goat is reduced by diarrhea or intoxicated by
antimicrobials, there may be a need for fluid infusion to maximize balanced phar-
macokinetic/pharmacodynamic process of antimicrobials. Clinical correlates of
weight loss as a measure of dehydration (>5–12%) must be considered.
Drops=minute ¼
volume of infusion mlð Þ
time of infusion minð Þ
 drop factor drops=mlð Þ (25)
Infusion rate IRð Þ ¼ drug dose
1
drug conc
 drop factor (26)
Only half of calculated deficit should be administered in 1–2 h. Half replacement
in 4–6 h is safer and should be completed in 2 days [65]. Isotonic solutions such as
5% dextrose and 0.9% normal saline can be administered via all routes. But hypo-
tonic and hypertonic solutions should be administered intravenously to avoid tissue
reaction.
Weighted AUC approach accounts for a more powerful PK/PD link and reveals
uniqueness outcome of therapeutic indices and problems of antibiotic resistance
[66]. A combination of ampicillin/sulbactam (20 mg/kg) in ratio 2:1 was adminis-
tered to goat with elimination half-life of ampicillin (0.71  0.12 h), and sulbactam
(1.02  0.36 h) shows that the preparation could be administered at the same
dosing rate in both sheep and goats [67]. Also, intramuscular dose (2 mg/kg) of
cefquinome (Cobactan 2.5%) daily yielded effective MICs against a variety of sus-
ceptible pathogenic microbes of goat including Micrococcus luteus [68]. Serum con-
centration and AUC integrated with MIC values can predict clinical success. The
efficacy of macrolides, penicillins and tetracyclines is determined by the length of
time, the serum concentration exceeds the MIC of a pathogenic microbe. But
fluoroquinolones, aminoglycosides and metronidazole have concentration-
dependent bactericidal activity [69]. The ratio of Cmax/MIC indicates potential of
antibacterial activity. Amikacin has the lowest MIC90, whereas kanamycin has the
highest [55]. Co-administration of two or more drugs could also affect pharmacoki-
netics and pharmacodynamics of a drug. For example, West African dwarf goats are
more sensitive to sulfadimidine co-administered with piroxicam (Figure 2) [15].
4.4 Intraspecies and interspecies scaling of antimicrobials in goats
Variation is an important factor in development of antimicrobials for all species
of animals including wild and domestic goats. The problems encountered are how to
scale up the pharmacokinetic data from animals to human and how to extrapolate
in vitro data to in vivo data for efficacy and safety [70]. There is no enough data on
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toxicological effects of antimicrobials in goats. Hence, several extrapolations are
necessary in order to arrive at safe therapeutic and toxic doses [71]. The effective
therapeutic doses of some antimicrobials translated from goats to human are given
in Table 2.
The formulas used for calculation of extrapolated doses are as follows [13, 72, 73].
Human equivalent dose HEDð Þ ¼
animal dose animal Km
human Km
(27)
Metabolism constant Kmð Þ ¼
body surface area
body weight
(28)
But human body surface area BSAð Þ ¼ H0:528 W0:528  K (29)
whereas H = height, W = weight and K = constant.
But goat’s BSA = WO.67  103 and dosimetric adjustment factor (DAF) is body
weight of goat over body weight of humans and can be scaled up to 0.25, 0.33 and
0.58. However, body weight exponent of 0.67 and 103 safety factor should be
applied to goat, and the exponent of 0.528 should be applied to human weight and
height, respectively [72, 74].
4.5 Antimicrobial tissue residues in goats
Tissue residues of some antimicrobials above recommended thresholds are of
public health importance. The presence of sulfadimidine residues (>0.1 ppm) in the
liver, kidney, skeletal muscle, spleen, lung, brain and heart after administration of
the drug (100 mg/kg) shows that the withdrawal period is longer than 30 days.
Hence, sulfadimidine is not easily excreted in West African dwarf goats [13]. This
may be due to the presence of desamino-sulfonamide, a sulfadimidine metabolite
[75] which is eliminated slowly, thereby increasing the withdrawal time [76]. Lack
of adequate water to dilute crystals of sulfadimidine in the kidney can lead to
crystalluria that can consequently cause nephrosis in the affected animals [44], and
consumptions of meats with high residues of sulfadimidine can cause Steven-
Johnson syndrome in sensitive humans who may be slow or fast acetylators [13, 23].
Based on the tissue tolerance limit in cattle (5 ppm), the withdrawal period for
tulathromycin is 19 days in cattle and 34 days in goat when administered subcuta-
neously [5]. The quantity of erythromycin residues (2.06  0.36 μg) is above the
recommended threshold and may portend risk to public health. The bioavailability
of tylosin in goat is 72.6 2.3%, and its withdrawal period (48 h) [43] shows that
the higher the bioavailability, the lower may be the withdrawal period in milk.
Residues of antimicrobials in various tissues are presented in Table 3. A kid that
feeds on milk with residues of antimicrobials may be vulnerable to resistance of
microorganisms against the antimicrobials.
4.6 Antimicrobial resistance
Goats are exposed to antimicrobials via prevention, treatment of diseases and
growth promotion. This has caused the emergence of resistant Salmonella, Cam-
pylobacter, Pasteurella, Actinobacillus, Enterococcus and Escherichia species. The
resistance is transferred by genes. But good and improved management practices
and increased use of vaccines and probiotics could minimize emergence and spread
of resistance genes [77].Off-label use of antimicrobials in goats could also contribute
to emergence of resistance. Meanwhile, lack of official-generated data on conse-
quences of extra-label use of drugs in goats cannot rule out its potential risks to goats
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and other species of animals [78]. However, T-phage, transposon and integrin are used
for resistance gene transfer. Unfortunately, the worldwide consumption of antimicro-
bial drugs is increasing, and the manufacturing industries are not keeping pace. The
worst of it at the moment is the emergence of superbugs and super drugs. Therefore,
there is a need for green antibiotics to minimize the chance of resistance [79].
4.7 Determination of creatinine and glomerular filtration rate as indices of
renal function in goats
Kidneys are responsible for water-electrolyte balance in the body, usually affected
by activity-rest rhythm under hormonal influence. The diurnal changes are useful in
chronobiology and chronopharmacology [80]. Many xenobiotics including antimi-
crobials are toxic to the kidney, and renal impairment can be assessed using creatinine
clearance which is physiologically, pharmacologically and toxicologically related to
body weight, clearance, volume of urine creatinine, plasma creatinine, serum creati-
nine, urine volume, glomerular filtration rate, creatinine clearance, creatinine half-life
and depuration [81]. The plasma creatinine of Boer-Cross (0.60 mg/dl), Nubian
(0.55 mg/dl) and Spanish (0.57 mg/dl) goat have been reported [82], whereas creat-
inine value (1.03–1.24 mg/dl) has been reported for healthy captive, Persian wild goat
[83]. Area under curve could be used to determine creatinine clearance and plasma
clearance as demonstrated in the equations given below [81].
Dose Dð Þ ¼ AUC CrClþ 25½  (30)
Pcl ¼ CrClþ 25 (31)
CrCl ¼ Pcl–25 (32)
GFR ¼
14616:8
Crt1=2
(33)
Depuration Depð Þ ¼
Ucr
Pcr
(34)
Serum creatinine Scrð Þ ¼
Ucr
1440
 1000 1000 ml ¼ 1 lð Þ (35)
Creatinine clearance CrClð Þ ¼
Ucr
Pcr
 144 (36)
For example, paracetamol reduced glomerular filtration rate and induced less
urinary excretion of isoniazid. Also, renal handling of isoniazid involved glomerular
filtration, back diffusion and active tubular secretion [84]. Glomerular filtration
rate which is a function of creatinine clearance can be affected by environmental
and genetic factors as may be seen in native Pakistan goats administered ampicillin
(20 mg/kg) with renal clearance of 0.08 ml/min/kg [85]. Hence, GFR is lower in
Pakistan native than the foreign goats [86] unlike renal handling of marbofloxacin
in Lohi sheep that involves both glomerular filtration and active tubular secretion
[87] indicating that environment has physiological effects on various breeds of
goats. This agrees with Bergmann’s rule which states that light animals tend to live
in hot regions of the world as opposed to fatty animals that tend to live in cold
regions [88]. Since 8% of total body weight determines total blood volume, red cell
volume and plasma volume could also be determined from hematocrit as indicated
in the equation given below [89].
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Total blood volume ¼ plasma 100=100–hematocrit (37)
Long-time administration of sulfadimidine over a period of 1 week may cause
hemolysis leading to anemia [90]. Hence, the formula can be used to determine
anemia and plasma deficit in goats, photos 1-46 [1, 2, 21, 22, 24].
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1, Abergelle goat; 2, Afar goat; 3, African pygmy goat; 4, Altai mountain goat; 5, American Alpine
doe; 6, Anglo Nubian goat; 7, Angora goat; 8, Ardi goats in the Arabian Peninsula; 9, Attappady black
goat; 10, Babrbari-goat-breed; 11, Beetal-South Asia; 12, Black Bengal goat; 13, Black Oberhasli;
14, Bosque Valley Boer goats; 15, British primitive (Feral goat); 16, Dairy goat; 17, Dutch Toggenburger;
18, Eid-goat; 19, Indian Boer male goat; 20, Italian Adamello blond; 21, Kalahari-red-goat; 22,
Marciano-Granadina; 23, Markhor wild goat; 24, Markhor-Pakistan; 25, Murciana goat; 26, Nederlandse
Landgeit; 27, Nigeria West African dwarf goat; 28, Nubian blackgold goat; 29, Nubian-Ryan-Somma;
30, Oberhasli goats; 31, Osmanabadi goat; 32, Pakistan Bakra goat; 33, Paaltu Bakri-Nashik goat;
34, Shiba goat; 35, Pure-white-Tappra-teddy-male-goat; 36, Saanen-goat-in-Pakistan-Urdu;
37, Sangamneri-South Asia pro-poor; 38, Shatner goat; 39, Sirohi-male-kid-goat; 40, Sojat-goat;
41, Sokoto Red goat; 42, Teddy-tapra-bakra-goat; 43, Toggenburgerbok goat; 44, Toggenburg-Nigerian-
dwarf-Oberhasli-goat; 45, Valachian goat; 46, White Barbari-goat.
5. Conclusion
Pharmacokinetic, pharmacodynamic, intraspecies and extraspecies scaling are
some parameters that can affect physiological functions of antimicrobials in goats.
Lack of judicious and extralabel use of antimicrobials in goats could cause high
tissue residues and development of resistance by susceptible microorganisms
against the antimicrobials in both goats and humans. Tissue residues of
sulfadimidine may cause Stevens-Johnson syndrome in the vulnerable individuals.
Dehydrated goats may be more susceptible to antimicrobial toxicity. GFR can be
used to assess the level of kidney damage caused by antimicrobials, and rehydration
therapy is useful in dissolution of antimicrobial crystals formed in the kidney. In
case of fervent need for extralabel use of antimicrobials, the relevant formulas
reported herein could be used to translate goat dose to human dose and vice versa.
Author details
Saganuwan Alhaji Saganuwan
Federal University of Agriculture Makurdi, Nigeria
*Address all correspondence to: pharn_saga2006@yahoo.com
©2019 TheAuthor(s). Licensee IntechOpen. This chapter is distributed under the terms
of theCreativeCommonsAttribution License (http://creativecommons.org/licenses/
by/3.0),which permits unrestricted use, distribution, and reproduction in anymedium,
provided the original work is properly cited.
18
Goats (Capra)
References
[1]Williamson G, Payne WJA. An
Introduction to Animal Husbandry in
the Tropics. London: Longman; 1978.
p. 483
[2] Ademosun AA. Trends in small
ruminant production for the last two
decades and its future in West and
Central Africa. In: Adeniji KO, editor.
Importance of Small Ruminant. Nairobi:
OAU; 1988. pp. 18-22
[3] Toutain PL, Ferran A, Bousquet-
Melou A. Species differences in
pharmacokinetics and
pharmacodynamics. In: Cunningham F,
Elliot J, Lees P, editors. Comparative
and Veterinary Pharmacology. Berlin:
Springer; 2010. pp. 19-48
[4] Ali BH, Charles BG, Al-Yousif M,
Bashir AK. Comparative
pharmacokinetics of metronidazole in
camels, sheep and goats. Acta
Veterinaria Brno. 2003;72:49-53
[5] Romanet J, Smith GW, Leavens TL,
Baynes RE, Wetzlich SE, Riviere JE,
et al. Pharmacokinetics and tissue
elimination of tulathromycin following
subcutaneous administration in meat
goats. AJVR. 2012;73(2):1634-1640
[6] Elmas M, Tras B, Kaya S, Bas AL,
Yazar E, Yarsan E. Pharmacokinetics of
enrofloxacin after intravenous and
intramuscular administration in Angora
goats. Canadian Journal of Veterinary
Research. 2001;le5:64-67
[7] Javed I, Nawaz M, Khan FH.
Pharmacokinetics and optimal dosage of
kanamycin in domestic ruminant
species. Veterinarski Arhiv. 2003;73(6):
323-331
[8]Agrawal AK, Singh SD, Jayachandran
C. Effect of fever on pharmacokinetics
and dosage regimen of intramuscularly
administered amikacin in goats. Journal
of Veterinary Science. 2001;2(2):91-96
[9] RamM, SinghV, Roy BK, Prasad R,
Singh KK. Effect ofmastitis on
pharmacokinetics of levofloxacin
following single dose intravenous
administration in goats. Journal of
Bioanalysis&Biomedicine. 2011;3(4):
081-084
[10] Al Nazaw MH. Comparative
pharmacokinetics studies on ampicillin
in camels, sheep and goats. Pakistan
Journal of Biological Sciences. 2003;
6(11):1005-1008
[11]Aktas I, Tarsan E. Pharmacokinetics of
conventional and long-acting
oxytetracycline preparations in kais goat.
Frontiers inVeterinaryScience. 2017;4:229
[12]Nureen H, Igbal Z, Hasnain J, Khan
AA. Biodisposition of isoniazid after oral
administration in teddy goats. Israel
Medical Journal. 2011;3(1):07-09
[13] Akogwu EI, Saganuwan SA,
Onyeyili PA. Effects of piroxicam on
tissue distribution of sulfadimidine in
west African dwarf male and female
goats. HET. 2018;37(1):61-68
[14] Zhao R, Xiao W, Wang Y, Yan X,
Zhou Z, Li J, et al. Initial observation of
the bacteriostasis activity and toxicity
of NAQO and MCEQO. Journal of
Traditional Clinical Veterinary Medicine.
1982;1:51-54
[15] Akogwu EI, Saganuwan SA,
Onyeyili PA. Effects of piroxicam on
pharmacokinetics of sulphadimidine in
west African dwarf male and female
goats (Capra hircus). Pharmaceutica
Analytica Acta. 2017;8(555):1-7
[16]Nawaz M, Khan FH.
Pharmacokinetics and urinary excretion
of sulphadimidine in sheep and goats.
Journal of Veterinary Pharmacology and
Therapeutics. 1979;2:129-132
[17] Elbadawy M, Ishihara T, Aboubakar
M, Sasaki K, Shimoda M. Oral
19
Unique Pharmacokinetic and Pharmacodynamic Parameters of Antimicrobials in Goats
DOI: http://dx.doi.org/10.5772/intechopen.84551
absorption profiles of sulfonamides in
Shiba goats: A comparison among
sulfadimidine, sulfadiazine and
sulfanilamide. The Journal of
Veterinary Medical Science. 2016;78(6):
1025-1029
[18] Van Gogh H, Van Deurzen EJM,
Van Duin CTM, Van Miert ASJPAM.
Effect of staphylococcal enterotoxin β-
induced diarrhoea on the
pharmacokinetics of sulphadimidine in
the goats. Journal of Veterinary
Pharmacology and Therapeutics. 1984;7:
303-305
[19] Elsheikh HA, Ali BH, Homeida AM,
Hassan T, Hapke HJ. Pharmacokinetics
of antipyrine and sulphadimidine
(sulfamethazine) in camels, sheep and
goats. Journal of Veterinary
Pharmacology and Therapeutics. 1991;
14:269-275
[20] Van Gogh H. Pharmacokinetics of
nine sulphonamides in goats. Journal of
Veterinary Pharmacology and
Therapeutics. 1980;3:69-81
[21] Fox JL, Smith CA, Scoen JW.
Relations between mountain goats and
their habitat in Southern Alaska.
Department of Agriculture, Forest
Services ,Pacific Northwest Research
Station, General Technical Report,
PNW-GTR-245. 1989. p. 30
[22]Dong Y, Zhang X, Xie M, Arefnezad
B, Wang Z, Wang W, et al. Reference
genome of wild goat (Capra aegagrus)
and sequencing of goat breeds provide
insight into genic basis of goat
domestication. BMC Genomics. 2015;
5(16):431
[23] Saganuwan SA. Therapeutic causes
of Stevens-Johnson syndrome—A mini
review. Open Access Journal of
Toxicology. 2017;1(2):001-004
[24] Alberto FJ, Boyer F,
OrozcoterWengel P, Streeter I, Servin B,
de Villemeruil P, et al. Convergent
genomic signatures of domestication in
sheep and goats. Nature
Communications. 2018;9(1):1-9
[25]Gould K. Antibiotics: From history
to the present day. The Journal of
Antimicrobial Chemotherapy. 2016;71:
572-575
[26]Goudah A, Abo-el-soud K.
Pharmacokinetics, urinary excretion
and milk penetration of levofloxacin in
lactating goats. Journal of Veterinary
Pharmacology and Therapeutics. 2008;
32:101-104
[27]Ola AK, Sandhu HS, Dumka VK,
Ranjan B. Pharmacokinetics, urinary
excretion and plasma protein binding of
ofloxacin in water buffalo calves
(Bubalus bubalis). Journal of the South
African Veterinary Association. 2013;
84(1):1-4
[28]Gond VK, Jayachandran C.
Comparative pharmacokinetics of three
commercial preparations of 10%
enrofloxacin following intravenous
administration of goats. International
Journal of Current Microbiology and
Applied Sciences. 2018;7:5200-5204
[29] Teare JA, Raphael BL, Bush N.
Pharmacokinetics of intravenous and
intramuscular gentamicin in Markhor
(Capra falconeri). Journal of Zoo Animal
Medicine. 1998;19(3):110-115
[30] Raina R, Prawez S, Dimitrova DJ,
Pankai NK, Verma PK. Disposition
kinetics and urinary excretion of
ciprofloxacin in goats following single
intravenous administration. Journal of
Veterinary Science. 2008;9(3):241-245
[31]Wajeeha FHK, Javed I.
Bioavailability and pharmacokinetics of
norfloxacin after intramuscular
administration in goats. Pakistan
Veterinary Journal. 2006;26(1):14-16
[32] Verma DK, Roy BK. Milk kinetics of
gatifloxacin after single dose
intravenous administration in healthy
20
Goats (Capra)
and febrile goats. International Journal
of Pharmaceutics. 2006;38(5):366-367
[33] Sharma N, Dumka VK.
Pharmacokinetics of lincomycin
following intravenous administration in
febrile goats. Indian Journal of Animal
Sciences. 2018;52(4):605-609
[34] Sharma N, Vemu B, Dumka VK.
Pharmacokinetics of lincomycin
following single intramuscular
administration in goats. International
Journal of Agricultural Science and
Research. 2017;7(2):555-560
[35] Grismer B, Rowe JD, Carlson J,
Wetzlich SE, Tell LA. Pharmacokinetics
of tulathromycin in plasma and milk
samples after a single subcutaneous
injection in lactating goats (Capra
hircus). Veterinary Pharmacology and
Therapeutics. 2014;37(2):205-208. DOI:
https://doi.org/10.1111/jvp.12071
[36]Malik JK, Rao GS, Muruganadan S,
Tripattu HC, Shukla DC.
Pharmacokinetics of pefloxacin in goats
after intravenous or oral administration.
Veterinary Research Communications.
2002;26(2):141-149
[37] Barot DK, Bhavsar SK, Sadariya KA,
Soni HH, Patel RJ, Patel JH, et al.
Pharmacokinetics of cefpirome
following intravenous and
intramuscular administration in goats.
Israel Journal of Veterinary Medicine.
2013;68(2):106-110
[38] Carceles CM, Funt A, Espuny A,
Fernandez-Varon E, Serrano JM,
Esaudero E. Pharmacokinetics of
azithromycin after intravenous and
intramuscular administration to goats.
Journal of Veterinary Pharmacology and
Therapeutics. 2005;28(1):51-55
[39] Ambros L, Montoya L, Kreil V,
Waxman S, Albarellos G, Rebuelto M,
et al. Pharmacokinetics of erythromycin
in non-lactating and lactating goats after
intravenous and intramuscular
administration. Journal of Veterinary
Pharmacology and Therapeutics. 2007;
30:80-85
[40] Li P, Xie W, Zhang X, Tian Z, Hao
C. Pharmacokinetics of mequindox after
intravenous and intramuscular
administration in goat. African Journal
of Biotechnology. 2010;9(49):8472-8476
[41] Tiwari S, Swati, Bhausar SK, Patel
ID, Thaker AM. Disposition of
ceftriaxone in goats (Capra hircus). Vet
Scan. 2009;4(2):6973-6980
[42]Waxman S, Rodriguez C, Gonzalez
F, De Vicente ML, San Andres MI, San
Andres MD. Pharmacokinetic behaviour
of marbofloxacin after intravenous and
intramuscular administration in adult
goats. Journal of Veterinary
Pharmacology and Therapeutics. 2001;
24(6):375-378
[43] Atef M, Youssef SAH, Atta AH, El-
Maaz AA. Disposition of tylosine in
goats. The British Veterinary Journal.
1991;147:207-215
[44] Kemper N. Veterinary antibiotics in
the aquatic and terrestrial environment.
Ecological Indicators. 2008;8(1):1-13
[45] Rule R, Villagra S, Barrena P,
Lachini R, Reynaldi FJ.
Pharmacokinetics of ceftazidime
administered to lactating and non
lactating goats. South African
Veterinary Association. 2011;82(4):
219-223
[46] Kanfer I. Report on the
international workshop on the
biopharmaceutical classification system
(BCS): Scientific and regulatory aspects
in practice. Journal of Pharmacy and
Pharmaceutical Sciences. 2002;5(1):1-4
[47] Baggot JD. The Physiological Basis
of Veterinary Clinical Pharmacology.
Oxford: Blackwell Science; 2001. p. 298
[48] Saganuwan SA. Principles of
Pharmacological Calculations. 1st ed.
21
Unique Pharmacokinetic and Pharmacodynamic Parameters of Antimicrobials in Goats
DOI: http://dx.doi.org/10.5772/intechopen.84551
Zaria, Nigeria: Ahmadu Bello University
Ltd.; 2012. p. 529
[49] Riviera JE, Martin-Jimenez T,
Sundlift SF, Craigmil AC. Interspecies
allometric analysis of the comparative
pharmacokinetics of 44 drugs across
veterinary and laboratory animal
species. Journal of Veterinary
Pharmacology and Therapeutics. 1997;
20:453-463
[50] Fang W, Pyoralla S. Mastitis-
causing Escherichia coli serum sensitivity
and susceptibility to selected
antibacterial in milk. Journal of Dairy
Science. 1996;79:76-82
[51] Aboubakar MH. Evaluation of
bioequivalence of two enrofloxacin
formulation after intramuscular
administration in goats. Korean Journal
of Veterinary Research. 2013;53(2):
77-82
[52]Wijesekala RNK, Kumbukgolla WW,
Jayaweera JAA, Rawat D. Review on
usage of vancomycin in livestock and
humans: Maintaining its efficacy
prevention of resistance and alternative
therapy. Veterinary Sciences. 2017;4(6):
1-11
[53]Garcia OH, Gorla N, Poloni G, Tritti
N, Prieto G, Errecalde C. Intravenous
pharmacokinetics of ciprofloxacin in
goats. International Journal of
Antimicrobial Agents. 2010;15(1):77-79
[54] Gentilini E, Denamiel G, Betanor A,
Rebuells M, Rodriguez FM, De Torres
RA. Antimicrobial susceptibility of
coagulase-negative staphylococci
isolated from bovine mastitis in
Argentina. Journal of Dairy Science.
2002;85:1913-1927
[55]Dinev T, Urumok V, Lyutskanov M,
Lasher L. Comparative
pharmacokinetics and PK/PD
parameters of five aminoglycosides in
goats. Turkish Journal of Veterinary and
Animal Sciences. 2009;33(3):223-228
[56] Anika SM, Nouws JF, Van Gogh H,
Nieuwenhuijs J, Viree TB, Van Mierts
AS. Chemotherapy and
pharmacokinetics of some antimicrobial
agents in healthy dwarf goats and
those infected with Ehrlichia
phagocytophila (tick-borne fever).
Research in Veterinary Science. 1986;
41(3):386-390
[57] Page SW, Gantier P. Use of
antimicrobial agents in livestock. Revue
Scientifique et Technique
(International Office of Epizootics).
2012;31(1):145-188
[58] Taverne FJ, van Geijlswijk IM,
Heederick DJJ, Wagenaar JA, Mouton
JW. Modelling concentrations of
antimicrobial drugs: Comparative
pharmacokinetics of cephalosporin
antimicrobials and accuracy of
allometric scaling in food-producing
and companion animals. BMC
Veterinary Research. 2016;12:185
[59] Kreil V, Ambros L, Prados AP,
Tarragona L, Monfrinotti A, Bramuglia
G, Rebuelto M. Pharmacokinetics of
immediate and sustained release
cephalexin administered by different
routes to Llamas (Lama glama).
Advances in Pharmacological Sciences
2016: ID 4621039.
[60] Stegemann MR, Sherington J,
Blanchflower S. Pharmacokinetics and
pharmacodynamics of cefovecin in
dogs. Journal of Veterinary
Pharmacology and Therapeutics. 2006;
29(6):501-511
[61] Stegemann MR, Sherington J, Coati
N, Brown SA, Blanchflower S.
Pharmacokinetics of cefovecin in cats.
Journal of Veterinary Pharmacology and
Therapeutics. 2006;29(6):513-524
[62] Lewicki J. Tylosin: A Review of
Pharmacokinetics, Residues in Food
Animals and Analytical Methods.
Warsaw, Poland: United Nations, Food
and Agricultural Organization; 1991
22
Goats (Capra)
[63] Avinash GD, Divyesh K, Madhavi
A, Bhavesh C, Hitesh P, Shailesh M.
Pharmacokinetics of orbifloxacin in
Mehsana goats after intravenous and
intramuscular administration.
Journal of Veterinary
Science and Technology. 2015;6:4
[64] Greenstem B. Trounce’s Clinical
Pharmacology for Nurses. 8th ed.
Churchill Livingstone: Elsevier Ltd.,
USA; 2009. p. 483
[65] Pugh DM. The fate of drug in the
body. In: Brander GC, Bywater RJ,
Jenkis WL, editors. Veterinary Applied
Pharmacology and Therapeutics. 6th ed.
UK:WB Saunders; 1992. p. 624
[66] Bi GDG, Li J, Nekka F.
Antimicrobial breakpoint estimation
accounting for variability in
pharmacokinetics. Theoretical Biology
and Medical Modelling. 2009;6:10
[67] Escudero E, Espuny A, Vicente MS,
Carceles CN. Comparative
pharmacokinetics of an ampicillin/
sulbactam combination administered
intramuscularly in lactating sheep and
goats. Veterinary Research. 1996;27(3):
201-208
[68] El-Hewaity M, Abd El Latif A,
Soliman A, Aboubakar M. Comparative
pharmacokinetics of cefquinome
(Cobactan 2.5%) following repeated
intramuscular administrations in sheep
and goats. Journal of Veterinary
Medicine. 2014:ID 949642
[69]Giguere S, Prescott JF, Dowling PM.
Antimicrobial Therapy in Veterinary
Medicine. 4th ed. Oxford: Wiley
Blacwell; 2006. p. 683
[70] Lin JH. Application and limitations
of interspecies scaling and in vitro
extrapolation in pharmacokinetics. Drug
Metabolism & Disposition. 1998;26(2):
1202-1212
[71] Kalberlah F, Fost U, Schneider K.
Time extrapolation and interspecies
extrapolation for locally acting
substances in case of limited
toxicological data. Annals of
Occupational Hygiene. 2002;46(2):
175-185
[72] Saganuwan SA, Onyeyili PA. The
paradox of human equivalent dose
formula: A canonical case study of
Abrus precatorius aqueous leaf extract
in monogastric animals.
Macedonian Veterinary Review. 2016;
39(1):23-32
[73] Saganuwan SA. Standardization and
scoring of the body surface area (bsa)
formulas for calculation of the doses of
anticancer patients from the North-
Western Nigeria. Journal of Cancer
Science and Therapy. 2015;7(1):012-018
[74] Saganuwan SA. Derivation of a
unique body surface area (bsa) formula
for calculation of relatively safe doses of
dog and human anticancer drugs.
Journal of Cancer Science and Therapy.
2017;9(10):690-704
[75]Wooley JL Jr, Siegel CW.
Development of pharmacokinetic
models for sulphonamides in food
animals: Metabolic depletion profile of
sulfadiazine in the calf. American
Journal of Veterinary Research. 1982;43:
768-774
[76] Kietzmann M. Metabolism of
sulphonamides. Archive Gelflugelkd.
1981;45:233-239
[77]McEwen SA, Fedorka PJ.
Antimicrobial use and resistance in
animals. Clinical Infectious Diseases.
2002;34(1):93-106
[78] European Medicine Agencxy
(EMA). Reflection paper on off-label
use of antimicrobials in veterinary
medicine in the European Union, EMA/
CVMP/AWP/237294/2017.
[79] Toutain PL, Ferran AA, Bousquet-
Melou A, Pelligand L, Lees P. Veterinary
23
Unique Pharmacokinetic and Pharmacodynamic Parameters of Antimicrobials in Goats
DOI: http://dx.doi.org/10.5772/intechopen.84551
medicine needs new green antimicrobial
drugs. Frontiers in Microbiology. 2016;
7:1-15
[80] Stotnicka E, Muszczynski Z,
Dudzinska W, Suska M. A review of the
renal system and diurnal variations of
renal activity in livestock. Irish
Veterinary Journal. 2007;60(3):161-168
[81] Saganuwan SA. The use of body
surface area for determination of age,
body weight, urine creatinine, plasma
creatinine, serum creatinine, urine
volume and creatinine clearance: The
reliable canonical method for assessing
renotoxicity in animals. Comparative
Clinical Pathology. 2018;27(4):1-6
[82] Turner KE, Wildeus S, Collins JR.
Intake, performance, and blood
parameters in young goats offered high
forage diets of lespedeza or alfalfa hay.
Small Ruminant Research. 2005;59:
15-23
[83]Omidi A, Nik HA, Nazifi S.
Biochemical reference values for healthy
captive Persian wild goat.
Comparative Clinical Pathology.
2017:1-10
[84]Hussain T, Javed I, Khan FH,
Muhammad F, Aslam B, Ahmad S.
Effect of paracetamol on the renal
clearance and urinary excretion of
isoniazid in goats. Pakistan Veterinary
Journal. 2009;29(3):121-124
[85]Nawaz M. Genetic variations of
ampicillin in indigenous sheep and goat
of Pakistan. In: 1st International
Congress of Veterinary Pharmacology
and Pharmaceutical Sciences; Oct 4-5,
2008; Tehran Iran
[86] Iqbal Z, Javed I, Aslam B,
Muhammad F, Jan IU. Renal clearance
and urinary excretion of ciprofloxacin in
goats. Pakistan Veterinary Journal.
2007;27(4):179-183
[87]Munawar SH, Iqbal, Manzoor Z.
Determination of renal handling of
marbofloxacin in Lohi sheep (Ovis aries)
following a single intravenous
administration. Iran Journal of
Veterinary Research. 2017;18(1):45-55
[88] Saganuwan SA. Toxicity studies of
drugs and chemicals in animals: An over
view. Bulgarian Journal of Veterinary
Medicine. 2017;20(4):1-28
[89] Saganuwan SA, Onyeyili PA.
Haematonic and plasma expander
effects of aqueous leaf extract of Abrus
precatorius inMus musculus.
Comparative Clinical Pathology. 2012;
21(5):1249-1255
[90] Saganuwan SA. Haematological and
biochemical effects of sulphadimidine in
Nigerian mongrel dog. Animal Research
International. 2006;3(2):457-460
24
Goats (Capra)
